TY - JOUR T1 - Increased risk for COVID-19 among Migrants from Latin-America, Caribbean, and Sub-Saharan Africa living in Spain JF - medRxiv DO - 10.1101/2020.05.25.20112185 SP - 2020.05.25.20112185 AU - Carlos Guijarro AU - Elia Pérez-Fernández AU - Beatriz González-Piñeiro AU - Victoria Meléndez AU - Maria José Goyanes AU - Mª Esther Renilla AU - Maria Luisa Casas AU - Isabel Sastre AU - María Velasco AU - Alcorcon COVID Investigators Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/27/2020.05.25.20112185.abstract N2 - Background There is scant information regarding risk for COVID-19 among migrants or ethnic minorities in Europe.Methods Population-based cohort analysis of the cumulative incidence of PCR-confirmed COVID-19 cases until April 25 (2020) among 152018 residents at the city of Alcorcón (Spain) attended at the only public hospital serving this city. Crude incident rates for Spaniards and migrants from different areas of the world were estimated. Age and sex-adjusted relative risks for COVID19 were estimated by negative polynomial regression.Findings PCR confirmed COVID-19 cumulative incidence was 6·81 cases per 1000 inhabitants among residents of Alcorcón. The crude incidence among migrants (n=20419) was higher than among Spaniards (n=131599): 8·81 and 6·51 and per 1000 inhabitants respectively (p<0·001). By regions of the world, crude cumulative COVID-19 incidences were Asia 2·1, European Union 2·4, Northern Africa 3·6, Russia & East Europe 4·4, Sub-Saharan Africa 11·2, Caribbean 18·3 and Latin-America 20·8 per 1000 inhabitants. By negative polynomial logistic regression, adjusted for age and sex, relative risks (RR) for COVID-19 were not significantly different from Spaniards for individuals from Europe, Asia or Northern Africa. In contrast, there was an increased risk for Sub-Saharan Africa (RR 3·66, 95% confidence interval (CI) 1·42-9·41, p=0·007), Caribbean (RR 6·35, 95% CI 3·83-10·55, p<0·001) and Latin-America (RR 6·92, 95% CI 4·49-10·67, p <0·001).Interpretation There was a marked increased risk for COVID-19 among migrants from Sub-Saharan Africa, Caribbean and Latin-America residing in Spain. Our data suggest a heretofore unreported increased risk in these populations that may deserve special attention.Evidence before this study Preliminary reports suggest an increased burden of COVID-19 among migrant or ethnic minorities in Western countries, particularly regarding mortality. Reports have failed to dissociate clinical outcomes from differences in access to medical care or pre-existing medical conditions.Added value of this study We report a population-based approach estimation of COVID-19 risks for migrants residing in Spain. Our data show a significant increased COVID-19 risk for migrants from Sub-Saharan Africa, and even higher for Caribbean and Latin-America migrants that cannot be attributed to unequal access to medical care.Implications of all the available evidence Migrants, particularly from some regions of the world deserve a closer attention.The increased risk may be of relevance for the evolution of the epidemics in Africa, the Caribbean and Latin-America. An underlying potential role of genetic / ethnic background deserves further researchCompeting Interest StatementThe authors have declared no competing interest.Funding StatementNo funding was available for this manuscriptAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB Hospital Universitario Fundacion AlcorconAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo individual patient data are avaiulable ER -